• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Dennd5b 缺陷小鼠对 PCSK9 诱导的高胆固醇血症和饮食诱导的肝脂肪变性具有抗性。

Dennd5b-Deficient Mice are Resistant to PCSK9-Induced Hypercholesterolemia and Diet-Induced Hepatic Steatosis.

机构信息

Saha Cardiovascular Research Center, University of Kentucky, Lexington, KY, USA.

Saha Cardiovascular Research Center, University of Kentucky, Lexington, KY, USA; Department of Physiology, University of Kentucky, Lexington, KY, USA.

出版信息

J Lipid Res. 2022 Dec;63(12):100296. doi: 10.1016/j.jlr.2022.100296. Epub 2022 Oct 13.

DOI:10.1016/j.jlr.2022.100296
PMID:36243100
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9685390/
Abstract

Dennd5b plays a pivotal role in intestinal absorption of dietary lipids in mice and is associated with body mass index in humans. This study examined the impact of whole-body Dennd5b deletion on plasma lipid concentrations, atherosclerosis, and hepatic lipid metabolism in mice. Hypercholesterolemia was induced in Dennd5b mice by infection with an adeno-associated virus expressing the proprotein convertase subtilisin/kexin type 9 serine protease (PCSK9) gain-of-function mutation (PCSK9D377Y) and feeding a Western diet for 12 weeks. Body weight and plasma lipid concentrations were monitored over 12 weeks, and then aortic atherosclerosis and hepatic lipid content were quantified. Compared to Dennd5b mice, Dennd5b mice were resistant to diet-induced weight gain and PCSK9-induced hypercholesterolemia. Atherosclerosis quantified by en face analysis and in aortic root sections, revealed significantly smaller lesions in Dennd5b compared to Dennd5b mice. Additionally, Dennd5b mice had significantly less hepatic lipid content (triglyceride and cholesterol) compared to Dennd5b mice. To gain insight into the basis for reduced hepatic lipids, quantitative PCR was used to measure mRNA abundance of genes involved in hepatic lipid metabolism. Key genes involved in hepatic lipid metabolism and lipid storage were differentially expressed in Dennd5b liver including Pparg, Cd36, and Pnpla3. These findings demonstrate a significant impact of Dennd5b on plasma and hepatic lipid concentrations and resistance to PCSK9-induced hypercholesterolemia in the absence of Dennd5b.

摘要

Dennd5b 在小鼠肠道对膳食脂质的吸收中发挥关键作用,并且与人类的体重指数相关。本研究旨在探讨全身性 Dennd5b 缺失对小鼠血浆脂质浓度、动脉粥样硬化和肝脏脂质代谢的影响。通过感染表达前蛋白转化酶枯草溶菌素/柯萨奇蛋白酶 9 丝氨酸蛋白酶(PCSK9)功能获得性突变(PCSK9D377Y)的腺相关病毒并给予西方饮食喂养 12 周,诱导 Dennd5b 小鼠发生高胆固醇血症。在 12 周的时间里,监测体重和血浆脂质浓度,然后定量分析主动脉粥样硬化和肝脏脂质含量。与 Dennd5b 小鼠相比,Dennd5b 小鼠对饮食诱导的体重增加和 PCSK9 诱导的高胆固醇血症具有抗性。通过正面分析和主动脉根部切片定量分析动脉粥样硬化,发现 Dennd5b 小鼠的病变明显小于 Dennd5b 小鼠。此外,Dennd5b 小鼠的肝脏脂质含量(甘油三酯和胆固醇)明显低于 Dennd5b 小鼠。为了深入了解肝脏脂质减少的基础,我们使用定量 PCR 测量了参与肝脏脂质代谢的基因的 mRNA 丰度。Dennd5b 肝脏中涉及肝脏脂质代谢和脂质储存的关键基因的表达水平存在差异,包括 Pparg、Cd36 和 Pnpla3。这些发现表明 Dennd5b 在缺乏 Dennd5b 的情况下对血浆和肝脏脂质浓度具有显著影响,并对 PCSK9 诱导的高胆固醇血症具有抗性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131c/9685390/de210f08d589/figs1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131c/9685390/ca9a57f98ba3/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131c/9685390/4ce62c2d552b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131c/9685390/cf0478d4ea0e/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131c/9685390/08d809bf4df7/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131c/9685390/1cdef06b9c45/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131c/9685390/0fcd41462181/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131c/9685390/67cb2fbddc17/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131c/9685390/6008736da16e/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131c/9685390/bd9bc7498db3/gr10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131c/9685390/de210f08d589/figs1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131c/9685390/ca9a57f98ba3/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131c/9685390/4ce62c2d552b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131c/9685390/cf0478d4ea0e/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131c/9685390/08d809bf4df7/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131c/9685390/1cdef06b9c45/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131c/9685390/0fcd41462181/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131c/9685390/67cb2fbddc17/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131c/9685390/6008736da16e/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131c/9685390/bd9bc7498db3/gr10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/131c/9685390/de210f08d589/figs1.jpg

相似文献

1
Dennd5b-Deficient Mice are Resistant to PCSK9-Induced Hypercholesterolemia and Diet-Induced Hepatic Steatosis.Dennd5b 缺陷小鼠对 PCSK9 诱导的高胆固醇血症和饮食诱导的肝脂肪变性具有抗性。
J Lipid Res. 2022 Dec;63(12):100296. doi: 10.1016/j.jlr.2022.100296. Epub 2022 Oct 13.
2
Hypercholesterolemia Induced by a PCSK9 Gain-of-Function Mutation Augments Angiotensin II-Induced Abdominal Aortic Aneurysms in C57BL/6 Mice-Brief Report.PCSK9功能获得性突变诱导的高胆固醇血症加剧C57BL/6小鼠中血管紧张素II诱导的腹主动脉瘤——简要报告
Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):1753-7. doi: 10.1161/ATVBAHA.116.307613. Epub 2016 Jul 28.
3
Proprotein convertase subtilisin/kexin type 9 (PCSK9): hepatocyte-specific low-density lipoprotein receptor degradation and critical role in mouse liver regeneration.前蛋白转化酶枯草杆菌蛋白酶/kexin 9型(PCSK9):肝细胞特异性低密度脂蛋白受体降解及在小鼠肝脏再生中的关键作用。
Hepatology. 2008 Aug;48(2):646-54. doi: 10.1002/hep.22354.
4
Targeting the proprotein convertase subtilisin/kexin type 9 for the treatment of dyslipidemia and atherosclerosis.针对枯草溶菌素转化酶 9 治疗血脂异常和动脉粥样硬化。
J Am Coll Cardiol. 2013 Oct 15;62(16):1401-8. doi: 10.1016/j.jacc.2013.07.056. Epub 2013 Aug 21.
5
Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.脂联素受体的激活调节前蛋白转化酶枯草溶菌素/克新9型的表达并抑制载脂蛋白E缺陷小鼠的病变。
Arterioscler Thromb Vasc Biol. 2017 Jul;37(7):1290-1300. doi: 10.1161/ATVBAHA.117.309630. Epub 2017 May 25.
6
microRNA-483 ameliorates hypercholesterolemia by inhibiting PCSK9 production.microRNA-483 通过抑制 PCSK9 的产生来改善高胆固醇血症。
JCI Insight. 2020 Dec 3;5(23):143812. doi: 10.1172/jci.insight.143812.
7
Gene inactivation of proprotein convertase subtilisin/kexin type 9 reduces atherosclerosis in mice.基因敲除丝氨酸蛋白酶 9 可减少小鼠动脉粥样硬化。
Circulation. 2012 Feb 21;125(7):894-901. doi: 10.1161/CIRCULATIONAHA.111.057406. Epub 2012 Jan 18.
8
Induction of sustained hypercholesterolemia by single adeno-associated virus-mediated gene transfer of mutant hPCSK9.通过单腺相关病毒介导的突变型人前蛋白转化酶枯草溶菌素9基因转移诱导持续性高胆固醇血症
Arterioscler Thromb Vasc Biol. 2015 Jan;35(1):50-9. doi: 10.1161/ATVBAHA.114.303617. Epub 2014 Oct 23.
9
The LEPIS-HuR-TMOD4 axis regulates hepatic cholesterol homeostasis and accelerates atherosclerosis.LEPIS-HuR-TMOD4 轴调节肝内胆固醇稳态并加速动脉粥样硬化。
Atherosclerosis. 2024 Jun;393:117554. doi: 10.1016/j.atherosclerosis.2024.117554. Epub 2024 Apr 16.
10
STK25 Regulates Cardiovascular Disease Progression in a Mouse Model of Hypercholesterolemia.STK25 调控高脂血症小鼠模型中心血管疾病的进展。
Arterioscler Thromb Vasc Biol. 2018 Aug;38(8):1723-1737. doi: 10.1161/ATVBAHA.118.311241.

引用本文的文献

1
PCSK9 with a gain of function D374Y mutation aggravates atherosclerosis by inhibiting PPARα expression.具有功能获得性D374Y突变的前蛋白转化酶枯草溶菌素9通过抑制过氧化物酶体增殖物激活受体α(PPARα)的表达加重动脉粥样硬化。
Sci Rep. 2025 Feb 26;15(1):6941. doi: 10.1038/s41598-025-91061-5.
2
DENND5B Gene Expression as a Trigger for the Development of Diabetes Mellitus-Peripheral Artery Disease: Insights from a Univariate and Multivariate Mendelian Randomization Study.DENND5B基因表达作为糖尿病-外周动脉疾病发生的触发因素:单变量和多变量孟德尔随机化研究的见解
Glob Heart. 2024 Dec 5;19(1):91. doi: 10.5334/gh.1373. eCollection 2024.
3
De novo variants in DENND5B cause a neurodevelopmental disorder.
DENND5B 中的新生变异导致神经发育障碍。
Am J Hum Genet. 2024 Mar 7;111(3):529-543. doi: 10.1016/j.ajhg.2024.02.001. Epub 2024 Feb 21.
4
New insights into the role of dietary triglyceride absorption in obesity and metabolic diseases.饮食中甘油三酯吸收在肥胖和代谢性疾病中的作用的新见解。
Front Pharmacol. 2023 Feb 2;14:1097835. doi: 10.3389/fphar.2023.1097835. eCollection 2023.